Literature DB >> 19197339

Regulation of human myoblast differentiation by PEBP4.

Reynaldo Garcia1, Joan Grindlay, Oliver Rath, Frances Fee, Walter Kolch.   

Abstract

The RAF-MEK-ERK pathway regulates both myoblast proliferation and differentiation; however, it is unclear how these events are coordinated. Here, we show that human phosphatidylethanolamine-binding protein 4 (PEBP4), a RAF kinase inhibitory protein (RKIP) family protein expressed preferentially in muscle, regulates the activity of the ERK pathway and myoblast differentiation by acting as a scaffold protein. In contrast to RKIP, which disrupts the RAF1-MEK interaction, PEBP4 forms ternary complexes with RAF1 and MEK, and can scaffold this interaction. PEBP4 expression is induced during the differentiation of primary human myoblasts. Consistent with the properties of a scaffold, PEBP4 enhances the RAF1-MEK interaction and the activation of MEK at low expression levels, whereas it inhibits these parameters at higher expression levels. Downregulation of PEBP4 by short hairpin RNA in human myoblasts increases MEK signalling and inhibits differentiation; by contrast, PEBP4 overexpression enhances differentiation. Thus, PEBP4 participates in the control of muscle cell differentiation by modulating the activity of MEK and ERK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197339      PMCID: PMC2658556          DOI: 10.1038/embor.2009.4

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  24 in total

1.  Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

Authors:  C Rommel; B A Clarke; S Zimmermann; L Nuñez; R Rossman; K Reid; K Moelling; G D Yancopoulos; D J Glass
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

2.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

3.  Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2.

Authors:  M Kortenjann; O Thomae; P E Shaw
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

4.  Regulation of Raf-1 activation and signalling by dephosphorylation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Zihni Yazici; Manfred Eulitz; Walter Kolch
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

5.  Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein.

Authors:  K Yeung; P Janosch; B McFerran; D W Rose; H Mischak; J M Sedivy; W Kolch
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis.

Authors:  Devasis Chatterjee; Yin Bai; Zhe Wang; Sandy Beach; Stephanie Mott; Rajat Roy; Corey Braastad; Yaping Sun; Asok Mukhopadhyay; Bharat B Aggarwal; James Darnowski; Panayotis Pantazis; James Wyche; Zheng Fu; Yasuhide Kitagwa; Evan T Keller; John M Sedivy; Kam C Yeung
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

7.  Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.

Authors:  Marion M Schuierer; Frauke Bataille; Suzanne Hagan; Walter Kolch; Anja-Katrin Bosserhoff
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

8.  Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.

Authors:  Zheng Fu; Peter C Smith; Lizhi Zhang; Mark A Rubin; Rodney L Dunn; Zhi Yao; Evan T Keller
Journal:  J Natl Cancer Inst       Date:  2003-06-18       Impact factor: 13.506

9.  A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization.

Authors:  Xiaojian Wang; Nan Li; Bin Liu; Hongying Sun; Taoyong Chen; Hongzhe Li; Jianming Qiu; Lihuang Zhang; Tao Wan; Xuetao Cao
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

10.  DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation.

Authors:  Takashi Yokoyama; Kazunori Takano; Akira Yoshida; Fumiko Katada; Peng Sun; Tadaomi Takenawa; Toshiwo Andoh; Takeshi Endo
Journal:  J Cell Biol       Date:  2007-05-29       Impact factor: 10.539

View more
  22 in total

1.  PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer.

Authors:  Gui-Ping Yu; Bin Huang; Guo-Qiang Chen; Song Wu; Yong Ji; Zhen-Ya Shen
Journal:  Tumour Biol       Date:  2011-11-12

2.  PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma.

Authors:  Dexiang Zhang; Yuedi Dai; Yuankun Cai; Tao Suo; Han Liu; Yueqi Wang; Zhijian Cheng; Houbao Liu
Journal:  Tumour Biol       Date:  2015-08-27

3.  The expression of PEBP4 protein in lung squamous cell carcinoma.

Authors:  Gui-Ping Yu; Guo-Qiang Chen; Song Wu; Kai Shen; Yong Ji
Journal:  Tumour Biol       Date:  2011-09-02

Review 4.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

5.  Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.

Authors:  Ren-qiang Huang; Dong-liang Shi; Wei Huang; Feng Chen; Yi-cheng Lu
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

6.  Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer.

Authors:  Hongyi Liu; Qingling Kong; Bing Li; Yuanxiang He; Peng Li; Baoqing Jia
Journal:  Tumour Biol       Date:  2011-11-29

7.  Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions.

Authors:  John M Sedivy
Journal:  For Immunopathol Dis Therap       Date:  2011

8.  Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt.

Authors:  David Romano; David Matallanas; Gregory Weitsman; Christian Preisinger; Tony Ng; Walter Kolch
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

9.  Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.

Authors:  Guiping Yu; Ning Zhong; Guoqiang Chen; Bin Huang; Song Wu
Journal:  Tumour Biol       Date:  2014-07-21

10.  PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis.

Authors:  Guiping Yu; Zhenya Shen; Guoqiang Chen; Xiaomei Teng; Yanqiu Hu; Bin Huang
Journal:  Tumour Biol       Date:  2012-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.